The global Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market was valued at US$ 2.3 billion in 2022 and is projected to surpass US$ 3.7 billion by the end of 2031, expanding at a CAGR of 5.0% from 2023 to 2031. Growing prevalence of abdominal aortic aneurysms, rapid advancements in endovascular technologies, and increasing adoption of minimally invasive surgical procedures are among the primary factors fueling market expansion worldwide.

Abdominal aortic aneurysm (AAA) is a potentially life-threatening condition characterized by the abnormal enlargement or weakening of the abdominal aorta, the body's largest artery. If left untreated, the aneurysm can rupture, leading to severe internal bleeding and a high risk of mortality. Consequently, healthcare providers are increasingly adopting endovascular repair devices that offer safer and less invasive treatment alternatives compared to traditional open surgery.

Rising Burden of Abdominal Aortic Aneurysm Driving Market Growth

The growing incidence of AAA is a major factor supporting demand for endovascular repair devices. The condition is predominantly observed among older adults and is strongly associated with risk factors such as smoking, hypertension, obesity, atherosclerosis, and high cholesterol levels.

The global aging population is creating a larger patient pool susceptible to vascular disorders, including aneurysms. According to public health statistics, aortic aneurysms and dissections continue to contribute significantly to cardiovascular-related mortality worldwide. Increased awareness regarding the importance of early diagnosis and preventive screening programs is further encouraging patients to seek timely treatment.

Governments, healthcare organizations, and medical institutions are promoting screening initiatives, particularly among high-risk populations such as men aged 65 years and older with a history of smoking. Such initiatives are expected to improve diagnosis rates and boost demand for advanced repair procedures during the forecast period.

Technological Advancements Transforming AAA Treatment

Technological innovation remains one of the strongest growth catalysts for the endovascular abdominal aortic aneurysm repair devices market. Endovascular aneurysm repair (EVAR) procedures have evolved significantly over the past decade, providing improved clinical outcomes and reducing procedural complications.

Unlike conventional open surgery, EVAR procedures involve small incisions through which specialized devices are delivered to the aneurysm site using catheter-based techniques. This minimally invasive approach offers several advantages, including reduced blood loss, shorter hospital stays, faster recovery times, and lower postoperative complications.

Modern EVAR devices incorporate advanced imaging compatibility, enhanced deployment mechanisms, and improved graft materials. Manufacturers are investing heavily in research and development to introduce next-generation stent-grafts capable of treating complex aneurysm anatomies with greater precision and durability.

The emergence of breakthrough technologies and innovative sealing systems is expected to expand treatment options for patients previously considered unsuitable for minimally invasive procedures.

Stent-Grafts Remain the Leading Product Segment

Based on product type, the market is segmented into synthetic fabric grafts and stent-grafts. Among these, the stent-graft segment accounted for the largest share of the market in 2022 and is expected to maintain its dominance throughout the forecast period.

Stent-grafts have become the preferred choice for EVAR procedures due to their effectiveness in isolating the aneurysm from blood circulation. These devices consist of a fabric-covered metallic framework that is inserted through the femoral artery and positioned at the aneurysm site using imaging guidance.

Once deployed, the stent-graft reinforces the weakened aortic wall and redirects blood flow through the graft, significantly reducing the risk of rupture. Continuous improvements in graft design and long-term durability are expected to strengthen segment growth in the coming years.

Growing Geriatric Population Supporting Demand

Age is one of the most significant risk factors associated with abdominal aortic aneurysms. Consequently, the geriatric age group represented the largest market segment in 2022.

As individuals age, arterial walls naturally lose elasticity and structural strength, increasing susceptibility to aneurysm formation. The rapid expansion of the elderly population across developed and developing nations is therefore creating sustained demand for endovascular repair procedures.

In addition to age-related vascular degeneration, older adults are more likely to experience associated risk factors such as hypertension, smoking history, and cardiovascular diseases, further contributing to market growth.

Increasing Adoption of Polymer-Based Materials

By material type, the market is divided into polymer and metal categories. Polymer-based materials held a dominant share in 2022 and are expected to continue leading the market throughout the forecast period.

Polymer materials offer several advantages, including flexibility, biocompatibility, durability, and resistance to corrosion. These properties make them highly suitable for manufacturing advanced graft systems used in endovascular repair procedures.

The growing focus on improving graft longevity and patient outcomes is encouraging manufacturers to incorporate innovative polymer technologies into next-generation devices.

Hospitals Continue to Dominate End-user Segment

Hospitals accounted for the largest share of the endovascular AAA repair devices market in 2022. The availability of specialized vascular surgeons, advanced imaging technologies, and comprehensive postoperative care makes hospitals the preferred treatment setting for aneurysm repair procedures.

Furthermore, increasing investments in healthcare infrastructure and expansion of vascular treatment capabilities are enabling hospitals to perform a larger volume of EVAR procedures. The growing availability of AAA treatment services in both developed and emerging healthcare systems is expected to further support segment growth.

North America Leads While Asia Pacific Emerges as High-Growth Region

Regionally, North America dominated the global market in 2022 due to the high prevalence of abdominal aortic aneurysms, strong healthcare infrastructure, and widespread adoption of advanced endovascular technologies.

The region also benefits from established screening programs and favorable reimbursement systems that encourage early diagnosis and treatment. Rising awareness among high-risk populations continues to support market expansion across the United States and Canada.

Meanwhile, Asia Pacific is expected to register the fastest growth rate during the forecast period. Increasing healthcare expenditure, expanding access to advanced vascular treatments, growing elderly populations, and rising incidence of cardiovascular diseases are driving demand across countries such as China, India, Japan, and Australia.

Competitive Landscape

The global endovascular abdominal aortic aneurysm repair devices market is fragmented, with several international and regional players competing through product innovation, strategic collaborations, and acquisitions.

Key companies operating in the market include Medtronic, Cook, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health Inc., Endologix, Inc., Lombard Medical Inc., Koninklijke Philips N.V., Terumo Medical Corporation, and W. L. Gore & Associates, Inc.

Industry participants continue to focus on developing technologically advanced stent-grafts and expanding their global presence through regulatory approvals and strategic partnerships. As demand for minimally invasive vascular interventions continues to rise, innovation and product differentiation are expected to remain central to competitive success through 2031.